Skip to main content

Cel Sci Corp

CVM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000725363

In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Cel Sci Corp changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CVM: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders671660
Shares6.22M774.7K5.97M+526.8K (+9.7%)
Value$7.22M$898.7K$6.32M+$2.62K (0.0%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Cel Sci Corp at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CVM in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.779,030$825.8K0.00%
Calton & Associates, Inc.47,140$50.0K0.02%
Kestra Advisory Services, LLC43,007$45.6K0.00%
Jane Street Group, LLC10,465$11.1K0.00%
Mindset Wealth Management, LLC10,200$10.8K0.00%
United Capital Management of KS, Inc.10,000$10.6K0.00%
Annapolis Financial Services, LLC978$1.04K0.00%
Darwin Advisors, LLC45$480.00%
Harbour Investments, Inc.10$110.00%
TD Waterhouse Canada Inc.4$40.00%
Householder Group Estate & Retirement Specialist, LLC211$00.00%

Sold out (11)

Institutions that held Cel Sci Corp at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CVM in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Renaissance Technologies LLC173,800$201.6K
D. E. Shaw & Co., Inc.53,215$61.7K
Millennium Management LLC50,636$58.7K
XTX Topco Ltd19,955$23.1K
Providence Wealth Advisors, LLC14,330$16.4K
Toroso Investments, LLC12,009$13.9K
Rhumbline Advisers1,220$1.42K
Missouri Trust & Investment Co1,040$1.21K
Family Firm, Inc.169$196
Qube Research & Technologies Ltd58$67
US Bancorp1$1

Not filed for Q3 2024 yet (1)

Institutions that held Cel Sci Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CVM in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.774,704$898.7K